{{Rsnum
|rsid=14978
|Gene=TMEM106B
|Chromosome=7
|position=12233526
|Orientation=minus
|GMAF=0.4183
|Gene_s=TMEM106B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.6 | 47.8 | 41.6
| HCB | 27.7 | 48.9 | 23.4
| JPT | 27.4 | 51.3 | 21.2
| YRI | 24.5 | 48.3 | 27.2
| ASW | 17.5 | 45.6 | 36.8
| CHB | 27.7 | 48.9 | 23.4
| CHD | 25.9 | 50.9 | 23.1
| GIH | 19.8 | 43.6 | 36.6
| LWK | 15.5 | 48.2 | 36.4
| MEX | 22.4 | 43.1 | 34.5
| MKK | 7.1 | 42.3 | 50.6
| TSI | 7.8 | 37.3 | 54.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=7E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}